The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Finasteride Tablets Market Research Report 2024
Synopsis
Finasteride, sold under the brand names Proscar and Propecia among others, is a medication used for the treatment of benign prostatic hyperplasia (BPH) and male pattern baldness (MPB).
The global Finasteride Tablets market was valued at US$ 118.4 million in 2023 and is anticipated to reach US$ 155.9 million by 2030, witnessing a CAGR of 3.9% during the forecast period 2024-2030.
North American market for Finasteride Tablets is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Finasteride Tablets is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Finasteride Tablets include Merck, Actavis, Sandoz, Teva Pharmaceuticals, Cipla, RelonChem, Dr. Reddy, Accord Pharmaceuticals and Henan Topfond, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Finasteride Tablets, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Finasteride Tablets.
Report Scope
The Finasteride Tablets market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Finasteride Tablets market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Finasteride Tablets manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck
Actavis
Sandoz
Teva Pharmaceuticals
Cipla
RelonChem
Dr. Reddy
Accord Pharmaceuticals
Henan Topfond
Zhejiang CONBA Pharmaceutical
Shandong Renhetang Pharmaceutical
Guangdong Eashu Pharmacetical
Segment by Type
1mg Tablet
5mg Tablet
Segment by Application
Benign Prostatic Hyperplasia
Male Pattern Baldness
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Finasteride Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Finasteride Tablets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Finasteride, sold under the brand names Proscar and Propecia among others, is a medication used for the treatment of benign prostatic hyperplasia (BPH) and male pattern baldness (MPB).
The global Finasteride Tablets market was valued at US$ 118.4 million in 2023 and is anticipated to reach US$ 155.9 million by 2030, witnessing a CAGR of 3.9% during the forecast period 2024-2030.
North American market for Finasteride Tablets is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Finasteride Tablets is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Finasteride Tablets include Merck, Actavis, Sandoz, Teva Pharmaceuticals, Cipla, RelonChem, Dr. Reddy, Accord Pharmaceuticals and Henan Topfond, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Finasteride Tablets, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Finasteride Tablets.
Report Scope
The Finasteride Tablets market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Finasteride Tablets market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Finasteride Tablets manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck
Actavis
Sandoz
Teva Pharmaceuticals
Cipla
RelonChem
Dr. Reddy
Accord Pharmaceuticals
Henan Topfond
Zhejiang CONBA Pharmaceutical
Shandong Renhetang Pharmaceutical
Guangdong Eashu Pharmacetical
Segment by Type
1mg Tablet
5mg Tablet
Segment by Application
Benign Prostatic Hyperplasia
Male Pattern Baldness
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Finasteride Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Finasteride Tablets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Finasteride Tablets Market Overview
1.1 Product Overview and Scope of Finasteride Tablets
1.2 Finasteride Tablets Segment by Type
1.2.1 Global Finasteride Tablets Market Value Comparison by Type (2024-2030)
1.2.2 1mg Tablet
1.2.3 5mg Tablet
1.3 Finasteride Tablets Segment by Application
1.3.1 Global Finasteride Tablets Market Value by Application: (2024-2030)
1.3.2 Benign Prostatic Hyperplasia
1.3.3 Male Pattern Baldness
1.3.4 Others
1.4 Global Finasteride Tablets Market Size Estimates and Forecasts
1.4.1 Global Finasteride Tablets Revenue 2019-2030
1.4.2 Global Finasteride Tablets Sales 2019-2030
1.4.3 Global Finasteride Tablets Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Finasteride Tablets Market Competition by Manufacturers
2.1 Global Finasteride Tablets Sales Market Share by Manufacturers (2019-2024)
2.2 Global Finasteride Tablets Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Finasteride Tablets Average Price by Manufacturers (2019-2024)
2.4 Global Finasteride Tablets Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Finasteride Tablets, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Finasteride Tablets, Product Type & Application
2.7 Finasteride Tablets Market Competitive Situation and Trends
2.7.1 Finasteride Tablets Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Finasteride Tablets Players Market Share by Revenue
2.7.3 Global Finasteride Tablets Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Finasteride Tablets Retrospective Market Scenario by Region
3.1 Global Finasteride Tablets Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Finasteride Tablets Global Finasteride Tablets Sales by Region: 2019-2030
3.2.1 Global Finasteride Tablets Sales by Region: 2019-2024
3.2.2 Global Finasteride Tablets Sales by Region: 2025-2030
3.3 Global Finasteride Tablets Global Finasteride Tablets Revenue by Region: 2019-2030
3.3.1 Global Finasteride Tablets Revenue by Region: 2019-2024
3.3.2 Global Finasteride Tablets Revenue by Region: 2025-2030
3.4 North America Finasteride Tablets Market Facts & Figures by Country
3.4.1 North America Finasteride Tablets Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Finasteride Tablets Sales by Country (2019-2030)
3.4.3 North America Finasteride Tablets Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Finasteride Tablets Market Facts & Figures by Country
3.5.1 Europe Finasteride Tablets Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Finasteride Tablets Sales by Country (2019-2030)
3.5.3 Europe Finasteride Tablets Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Finasteride Tablets Market Facts & Figures by Country
3.6.1 Asia Pacific Finasteride Tablets Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Finasteride Tablets Sales by Country (2019-2030)
3.6.3 Asia Pacific Finasteride Tablets Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Finasteride Tablets Market Facts & Figures by Country
3.7.1 Latin America Finasteride Tablets Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Finasteride Tablets Sales by Country (2019-2030)
3.7.3 Latin America Finasteride Tablets Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Finasteride Tablets Market Facts & Figures by Country
3.8.1 Middle East and Africa Finasteride Tablets Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Finasteride Tablets Sales by Country (2019-2030)
3.8.3 Middle East and Africa Finasteride Tablets Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Finasteride Tablets Sales by Type (2019-2030)
4.1.1 Global Finasteride Tablets Sales by Type (2019-2024)
4.1.2 Global Finasteride Tablets Sales by Type (2025-2030)
4.1.3 Global Finasteride Tablets Sales Market Share by Type (2019-2030)
4.2 Global Finasteride Tablets Revenue by Type (2019-2030)
4.2.1 Global Finasteride Tablets Revenue by Type (2019-2024)
4.2.2 Global Finasteride Tablets Revenue by Type (2025-2030)
4.2.3 Global Finasteride Tablets Revenue Market Share by Type (2019-2030)
4.3 Global Finasteride Tablets Price by Type (2019-2030)
5 Segment by Application
5.1 Global Finasteride Tablets Sales by Application (2019-2030)
5.1.1 Global Finasteride Tablets Sales by Application (2019-2024)
5.1.2 Global Finasteride Tablets Sales by Application (2025-2030)
5.1.3 Global Finasteride Tablets Sales Market Share by Application (2019-2030)
5.2 Global Finasteride Tablets Revenue by Application (2019-2030)
5.2.1 Global Finasteride Tablets Revenue by Application (2019-2024)
5.2.2 Global Finasteride Tablets Revenue by Application (2025-2030)
5.2.3 Global Finasteride Tablets Revenue Market Share by Application (2019-2030)
5.3 Global Finasteride Tablets Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Corporation Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck Finasteride Tablets Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Merck Finasteride Tablets Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 Actavis
6.2.1 Actavis Corporation Information
6.2.2 Actavis Description and Business Overview
6.2.3 Actavis Finasteride Tablets Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Actavis Finasteride Tablets Product Portfolio
6.2.5 Actavis Recent Developments/Updates
6.3 Sandoz
6.3.1 Sandoz Corporation Information
6.3.2 Sandoz Description and Business Overview
6.3.3 Sandoz Finasteride Tablets Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Sandoz Finasteride Tablets Product Portfolio
6.3.5 Sandoz Recent Developments/Updates
6.4 Teva Pharmaceuticals
6.4.1 Teva Pharmaceuticals Corporation Information
6.4.2 Teva Pharmaceuticals Description and Business Overview
6.4.3 Teva Pharmaceuticals Finasteride Tablets Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Teva Pharmaceuticals Finasteride Tablets Product Portfolio
6.4.5 Teva Pharmaceuticals Recent Developments/Updates
6.5 Cipla
6.5.1 Cipla Corporation Information
6.5.2 Cipla Description and Business Overview
6.5.3 Cipla Finasteride Tablets Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Cipla Finasteride Tablets Product Portfolio
6.5.5 Cipla Recent Developments/Updates
6.6 RelonChem
6.6.1 RelonChem Corporation Information
6.6.2 RelonChem Description and Business Overview
6.6.3 RelonChem Finasteride Tablets Sales, Revenue and Gross Margin (2019-2024)
6.6.4 RelonChem Finasteride Tablets Product Portfolio
6.6.5 RelonChem Recent Developments/Updates
6.7 Dr. Reddy
6.6.1 Dr. Reddy Corporation Information
6.6.2 Dr. Reddy Description and Business Overview
6.6.3 Dr. Reddy Finasteride Tablets Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Dr. Reddy Finasteride Tablets Product Portfolio
6.7.5 Dr. Reddy Recent Developments/Updates
6.8 Accord Pharmaceuticals
6.8.1 Accord Pharmaceuticals Corporation Information
6.8.2 Accord Pharmaceuticals Description and Business Overview
6.8.3 Accord Pharmaceuticals Finasteride Tablets Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Accord Pharmaceuticals Finasteride Tablets Product Portfolio
6.8.5 Accord Pharmaceuticals Recent Developments/Updates
6.9 Henan Topfond
6.9.1 Henan Topfond Corporation Information
6.9.2 Henan Topfond Description and Business Overview
6.9.3 Henan Topfond Finasteride Tablets Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Henan Topfond Finasteride Tablets Product Portfolio
6.9.5 Henan Topfond Recent Developments/Updates
6.10 Zhejiang CONBA Pharmaceutical
6.10.1 Zhejiang CONBA Pharmaceutical Corporation Information
6.10.2 Zhejiang CONBA Pharmaceutical Description and Business Overview
6.10.3 Zhejiang CONBA Pharmaceutical Finasteride Tablets Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Zhejiang CONBA Pharmaceutical Finasteride Tablets Product Portfolio
6.10.5 Zhejiang CONBA Pharmaceutical Recent Developments/Updates
6.11 Shandong Renhetang Pharmaceutical
6.11.1 Shandong Renhetang Pharmaceutical Corporation Information
6.11.2 Shandong Renhetang Pharmaceutical Finasteride Tablets Description and Business Overview
6.11.3 Shandong Renhetang Pharmaceutical Finasteride Tablets Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Shandong Renhetang Pharmaceutical Finasteride Tablets Product Portfolio
6.11.5 Shandong Renhetang Pharmaceutical Recent Developments/Updates
6.12 Guangdong Eashu Pharmacetical
6.12.1 Guangdong Eashu Pharmacetical Corporation Information
6.12.2 Guangdong Eashu Pharmacetical Finasteride Tablets Description and Business Overview
6.12.3 Guangdong Eashu Pharmacetical Finasteride Tablets Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Guangdong Eashu Pharmacetical Finasteride Tablets Product Portfolio
6.12.5 Guangdong Eashu Pharmacetical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Finasteride Tablets Industry Chain Analysis
7.2 Finasteride Tablets Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Finasteride Tablets Production Mode & Process
7.4 Finasteride Tablets Sales and Marketing
7.4.1 Finasteride Tablets Sales Channels
7.4.2 Finasteride Tablets Distributors
7.5 Finasteride Tablets Customers
8 Finasteride Tablets Market Dynamics
8.1 Finasteride Tablets Industry Trends
8.2 Finasteride Tablets Market Drivers
8.3 Finasteride Tablets Market Challenges
8.4 Finasteride Tablets Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
